Abstract
Activating transcription factor (ATF-3) is a stress response gene and is induced by transforming growth factor beta 1 (TGF-β1) in breast cancer cells. In this study, we dissected the functional role of ATF-3 gene in vitro by knocking down its expression stably in human bone metastatic breast cancer cells (MDA-MB231). Knockdown of ATF-3 expression in these cells decreased cell number, altered cell cycle phase transition, and decreased mRNA expression of cell cycle genes. Knockdown of ATF-3 expression in MDA-MB231 cells also decreased cell migration, and the expression levels of invasive and metastatic genes such as MMP-13 and Runx2 were found to be decreased in these cells. Most importantly, ATF-3 was associated with Runx2 promoter in MDA-MB231 cells and knockdown of ATF-3 expression decreased its association with Runx2 promoter. Hence, our results suggested that ATF-3 plays a role in proliferation and invasion of bone metastatic breast cancer cells in vitro and we identified for the first time that Runx2 is a target gene of ATF-3 in MDA-MB231 cell line.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Canc J Clin. 2011;61(2):69–90.
Rebecca S, Deepa Naishadham MA, Ahmedin Jemal DVM. Cancer statistics. CA Cancer J Clin. 2013;63:11–30.
Buijs JT, Van DPG. Osteotropic cancers: from primary tumor to bone. Canc Lett. 2009;273(2):177–93.
Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, et al. Osteoblast related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res. 2003;63:2631–7.
Sterling JA, Edwards JR, Martin TJ, Mundy GR. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone. 2011;48:6–15.
Bu G, Lu W, Liu CC, Selander K, Yoneda T, Hall C, et al. Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: Implication for breast cancer osteolytic bone metastases. Int J Cancer. 2008;123:1034–42.
Hai T, Hartman MG. The molecular biology and nomenclature of the ATF/CREB family of transcription factors: ATF proteins and homeostasis. Gene. 2001;273:1–11.
Ameri K, Hammond EM, Culmsee C, Raida M, Katschinski DM, Wenger RH, et al. Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene. 2007;26:284–9.
Gold ES, Ramsey SA, Sartain MJ, et al. ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol-induced lipid body formation. J Exp Med. 2012;209:807–17.
Jang MK, Kim CH, Seong JK, Jung MH. ATF3 inhibits adipocyte differentiation of 3 T3-L1 cells. Biochem Biophys Res Commun. 2012;421:38–43.
Rose CL, Chakravarti N, Curry JL. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol. 2012;39:762–8.
Kwok S, Rittling SR, Partridge NC, Benson CS, Thiyagaraj M, Srinivasan N, et al. Transforming growth factor-b1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells. J Cell Biochem. 2009;108:408–14.
Yin X, Wolford CC, Chang YS, McConoughey S, Ramsey SA, Aderem A, et al. ATF3, an adaptive-response gene, enhances TGF {beta} signaling and cancer-initiating cell features in breast cancer cells. J Cell Sci. 2010;123:3558–65.
Hagiya K, Yasunaga J, Satou Y, Ohshima K, Matsuoka M. ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology. 2011;8:19.
Liu W, Iiizumi-Gairani M, Okuda H, Kobayashi A, Watabe M, Pai SK, et al. KAI1 gene is engaged in NDRG1 gene-mediated metastasis suppression through the ATF3-NF{kappa}B complex in human prostate cancer. J Biol Chem. 2011;286:18949–59.
Lim JH, Lee HJ, Pak YK, Kim WH, Song J. Organelle stress-induced activating transcription factor-3 downregulates low-density lipoprotein receptor expression in Sk-Hep1 human liver cells. Biol Chem. 2011;392:377–85.
Yan L, Della Coletta L, Powell KL, Shen J, Thames H, Aldaz CM, et al. Activation of the canonical Wnt/b-catenin pathway in ATF3-induced mammary tumors. PLoS One. 2011;6:e16515.
Pratap J, Lian JB, Stein GS. Metastatic bone disease: Role of transcription factors and future targets. Bone. 2011;48:30–6.
Selvamurugan N, Partridge NC. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol Cell Biol Res Commun. 2000;3:218–23.
Selvamurugan N, Kwok S, Partridge NC. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-1-stimulated collagenase-3 expression in human breast cancer cells. J BiolChem. 2004;279:27764–73.
Pratap J, Lian JB, Javed A, Barnes GL, Van Wijnen AJ, Stein JL, et al. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 2006;25:589–600.
Tandon M, Chen Z, Pratap J. Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells. Breast Cancer Res. 2014;16:R16.
Wolford CC, McConoughey SJ, Jalgaonkar SP, Leon M, Merchant AS, Dominick JL, et al. Transcription factor ATF3 links host adaptive response to breast cancer metastasis. J Clin Investig. 2013;123(7):2893–906.
Miranda PJ, Vimalraj S, Selvamurugan N. A feedback expression of microRNA-590 and activating transcription factor-3 in human breast cancer cells. Int J Biol Macromol. 2014;72:145–50.
Saravanan S, Vimalraj S, Vairamani M, Selvamurugan N. Role of mesoporous wollastonite (calcium silicate) in mesenchymal stem cell proliferation and osteoblast differentiation: a cellular and molecular study. J Biomed Nanotechnol. 2015. doi:10.1166/jbn.2015.2057.
Vimalraj S, Selvamurugan N. MicroRNAs expression and their regulatory networks during mesenchymal stem cells differentiation toward osteoblasts. Int J Biol Macromol. 2014;66:194–202.
Vimalraj S, Partridge NC, Selvamurugan N. A positive role of microRNA-15b on regulation of osteoblast differentiation. J Cell Physiol. 2014;229:1236–44.
Shimizu E, Selvamurugan N, Westendorf JJ, Olson EN, Partridge NC. HDAC4 represses matrix metalloproteinase-13 transcription in osteoblastic cells, and parathyroid hormone controls this repression. J Biol Chem. 2010;285:9616–26.
Yoshizumi M, Hsieh CM, Zhou F, Tsai JC, Patterson C, Perrella MA, et al. The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells. Mol Cell Biol. 1995;15:3266–72.
Chen BP, Liang G, Whelan J, Hai T. ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem. 1994;269:15819–26.
James CG, Woods A, Underhill TM, Beier F. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription. BMC Mol Biol. 2006;7:30–40.
Zang S, Yu W, Chen H, Shi L, Li T, Chen A, et al. Expression of ATF3 and target genes cyclin D1 and maspin in colorectal cancer tissues. Chin J Cancer Prev Treat. 2012;19(24):1870–4.
Hao Z, Ao J, Zhang J, Su Y, Yang R. ATF3 activates Stat3 phosphorylation through inhibition of p53 expression in skin cancer cells. Asian Pacific J Cancer Prev. 2013;14(12):7439–44.
Selvamurugan N, Fung Z, Partridge NC. Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells. FEBS Lett. 2002;532:31–5.
Vimalraj S, Miranda PJ, Ramyakrishna B, Selvamurugan N. Regulation of breast cancer and bone metastasis by microRNAs. Dis Markers. 2013;35:369–87.
Pratap J, Javed A, Languino LR, van Wijnen AJ, Stein JL, Stein GS, et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol. 2005;25:8581–91.
Pratap J, Wixted JJ, Gaur T, Zaidi SK, Dobson J, Gokul KD, et al. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008;68:7795–802.
Himge NO, Frenkel B. The RUNX family in breast cancer: Relationships with estrogen signaling. Oncogene. 2013;32:2121–30.
Messeguer X, Escudero R, Farré D, Núñez O, Martínez J, Albà MM. PROMO: Detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333–4.
Acknowledgments
We thank S. Vimalraj for his technical help. This work was supported by the Indian Council of Medical Research, India (Grant No. 5/31/128/2009-NCD-III to N.S) and the Rajiv Gandhi National Fellowship (No. RGNF-2013-14-SC-TAM-42130 to M.G).
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gokulnath, M., Partridge, N.C. & Selvamurugan, N. Runx2, a target gene for activating transcription factor-3 in human breast cancer cells. Tumor Biol. 36, 1923–1931 (2015). https://doi.org/10.1007/s13277-014-2796-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-014-2796-x